Boehringer’s Commitment to Metabolic Diseases
Metabolic Diseases
Positioning in Cardiovascular, Renal and Metabolic Diseases
Our mission is to protect people from the consequences of cardiovascular, renal and metabolic diseases, and advocate for a shift from fragmented to integrated solutions that focus on prevention and treatment.
Read more
Metabolic Diseases
Innovation in Cardio-Renal-Metabolic Diseases
Cardiovascular, renal and metabolic diseases are connected conditions that can amplify each other. We are dedicated to delivering innovation for people living with these diseases both now, and for future generations.
Read more
Downloads
Cardiovascular, renal, and metabolic conditions infographic
Learn more about the Cardiovascular, renal, and metabolic conditions infographic.
Latest News on Metabolic Diseases
October 08, 2024
Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide
June 07, 2024